Company Kane Biotech Inc Other OTC
Equities
CA4838091094
Biotechnology & Medical Research
End-of-day quote
Other stock markets
|
||
- USD | - |
Apr. 18 | Transcript : Kane Biotech Inc. - Special Call | |
Apr. 15 | Kane Biotech Up 12% After Reporting Closing of STEM Animal Health Sale | MT |
Business Summary
Sales per Business
CAD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
All Other
100.0
%
| 0 | 5.9 % | 0 | 100.0 % | -4.95% |
Sales per region
CAD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
International
93.1
%
| 1 | 55.5 % | 0 | 93.1 % | -90.63% |
Canada
6.9
%
| 1 | 44.5 % | 0 | 6.9 % | -99.13% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Marc Edwards
CEO | Chief Executive Officer | - | 16-06-01 |
Ray Dupuis
DFI | Director of Finance/CFO | - | 17-09-04 |
Compliance Officer | - | 19-08-11 | |
Gregory Schultz
CTO | Chief Tech/Sci/R&D Officer | 73 | 22-04-04 |
John Coleman
BRD | Director/Board Member | - | Nov. 15 |
Wendy Nachtigall
SAM | Sales & Marketing | - | 15-09-30 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
R. Renaud
BRD | Director/Board Member | - | 10-09-14 |
Chairman | 59 | Feb. 19 | |
Georges Morin
BRD | Director/Board Member | - | 20-05-19 |
Marc Edwards
CEO | Chief Executive Officer | - | 16-06-01 |
John Coleman
BRD | Director/Board Member | - | Nov. 15 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 131,844,567 | 85,786,381 ( 65.07 %) | 0 | 65.07 % |
Company contact information
Sector
Sales per Business
Sales per region
1st Jan change | Capi. | |
---|---|---|
+25.69% | 48.09B | |
+46.90% | 40.62B | |
-3.46% | 40.43B | |
-6.20% | 28.36B | |
+9.17% | 24.89B | |
-20.42% | 19.01B | |
+28.07% | 12.09B | |
+0.17% | 11.88B | |
-1.24% | 11.8B |
- Stock Market
- Equities
- KNE Stock
- Stock
- Company Kane Biotech Inc